Literature DB >> 14734019

Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans.

Naseem Akhtar Gaur1, Neeti Puri, Neerja Karnani, Gauranga Mukhopadhyay, Shyamal K Goswami, Rajendra Prasad.   

Abstract

We have earlier shown that transcriptional activation of the Candida drug resistance gene, CDR1, is linked to various stresses wherein a proximal promoter (-345 bp from the transcription start point (TSP)) was found to be predominantly more responsive. In this study we have examined basal expression of the CDR1 proximal promoter by employing a Renilla luciferase reporter system. We observed that upon sequential deletion of the proximal promoter, there was modulation in basal reporter activity. The reporter activity was highest (2.3-fold) in NGY261 (-261 bp from TSP), and was reduced upon subsequent deletions. DNase I footprinting revealed four protected regions (W1, W2, W3 and W4) in the proximal promoter which could represent possible trans-acting factor binding sites and thus might be involved in CDR1 expression. Site-directed mutational analysis of three of these protected regions did not significantly affect the basal reporter activity, however, the mutation of W1 led to a considerable enhancement in reporter activity (approximately 4-fold) and was designated a negative regulatory element (NRE). Mutation as well as deletion of the W1 sequence in the native promoter (-1147 bp from TSP) and sequential deletion of the 5'-flanking region-harboring W1 (NRE) also resulted in enhanced promoter reporter activity. When the reporter activity of native (NPY1147) and NRE-mutated (NGYM1147) promoter integrants was monitored throughout the growth phase of Candida albicans, there was modulation in reporter activity in both integrants, but interestingly the level of basal reporter activity of the NRE-mutated promoter was always approximately 3-fold higher than that of the native promoter. UV cross-linking and affinity purification confirmed that a purified approximately 55-kDa nuclear protein specifically interacts with the NRE. Taken together, we have identified a NRE and purified its interactive protein, which may be involved in controlling basal expression of CDR1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734019     DOI: 10.1016/S1567-1356(03)00204-6

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  12 in total

Review 1.  Multidrug resistance in fungi.

Authors:  Kailash Gulshan; W Scott Moye-Rowley
Journal:  Eukaryot Cell       Date:  2007-09-14

2.  Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system.

Authors:  Alix T Coste; Jérôme Crittin; Christopher Bauser; Bettina Rohde; Dominique Sanglard
Journal:  Eukaryot Cell       Date:  2009-06-26

3.  TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.

Authors:  Alix T Coste; Mahir Karababa; Françoise Ischer; Jacques Bille; Dominique Sanglard
Journal:  Eukaryot Cell       Date:  2004-12

4.  Transcriptional regulatory circuitries in the human pathogen Candida albicans involving sense--antisense interactions.

Authors:  Ausaf Ahmad; Anatoliy Kravets; Elena Rustchenko
Journal:  Genetics       Date:  2011-11-30       Impact factor: 4.562

5.  Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.

Authors:  Shipra Shukla; Vipin Yadav; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Eukaryot Cell       Date:  2011-08-19

Review 6.  Fungal infections in pediatric neurosurgery.

Authors:  Adrian Caceres; Maria Luisa Avila; Marco Luis Herrera
Journal:  Childs Nerv Syst       Date:  2018-08-18       Impact factor: 1.475

7.  A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.

Authors:  Alix Coste; Vincent Turner; Françoise Ischer; Joachim Morschhäuser; Anja Forche; Anna Selmecki; Judith Berman; Jacques Bille; Dominique Sanglard
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

8.  Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.

Authors:  Nico Dunkel; Julia Blass; P David Rogers; Joachim Morschhäuser
Journal:  Mol Microbiol       Date:  2008-05-27       Impact factor: 3.501

9.  Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans.

Authors:  Raman Manoharlal; Naseem Akhtar Gaur; Sneh Lata Panwar; Joachim Morschhäuser; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

Review 10.  Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans.

Authors:  Saif Hameed; Zeeshan Fatima
Journal:  Int J Microbiol       Date:  2013-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.